Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Internal Medicine Journal|October 17, 2018
Revisiting acquired aplastic anaemia: current concepts in diagnosis and managementDanielle B Clucas, Lucy C Fox, Erica M Wood, et al.
Nature Medicine|November 21, 2018
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphomaRishu Agarwal, Yih-Chih Chan, Constantine S Tam, et al.
Haematologica|January 14, 2014
The SKI proto-oncogene enhances the in vivo repopulation of hematopoietic stem cells and causes myeloproliferative diseaseSofie Singbrant, Meaghan Wall, Jennifer Moody, et al.
Nucleic Acids Research|December 24, 2010
c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiationGretchen Poortinga, Meaghan Wall, Elaine Sanij, et al.
Nephrology (Carlton, Vic.)|February 9, 2018
Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New ZealandLucy C Fox, Solomon J Cohney, Joshua Y Kausman, et al.
Blood|January 28, 2017
Molecular disease monitoring using circulating tumor DNA in myelodysplastic syndromesPaul Yeh, Michael Dickinson, Sarah Ftouni, et al.
Pathology|April 24, 2022
Panel-based gene testing in myelodysplastic/myeloproliferative neoplasm overlap syndromes: Australasian Leukaemia and Lymphoma Group (ALLG) consensus statementAnoop K Enjeti, Rishu Agarwal, Piers Blombery, et al.
Internal Medicine Journal|March 28, 2018
Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New ZealandLucy C Fox, Solomon J Cohney, Joshua Y Kausman, et al.
Blood Advances|July 24, 2026
Long-term outcomes with continuous venetoclax for relapsed chronic lymphocytic leukemiaSean McKeague, Thomas E Lew, Anna Lowe, et al.
Blood|April 4, 2020
BTK inhibitor therapy is effective in patients with CLL resistant to venetoclaxVictor S Lin, Thomas E Lew, Sasanka M Handunnetti, et al.
Pageof 16